Skip Navigation

Strengthening the evidence for maternal and child health programs

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.


Displaying records 1 through 16 (16 total).

U.S. Food and Drug Administration, Office of Consumer Affairs. 2020. Vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ENDS). Rockville, MD: U.S. Food and Drug Administration, Office of Consumer Affairs, 1 v.

Annotation: This resource describes types, ingredients, and components of electronic nicotine delivery systems (ENDS) including vaporizers, vape pens, hookah pens, electronic cigarettes (e-cigarettes), and e-pipes. Additional topics include what ENDS look like; statistics about ENDS use; FDA regulation of ENDS; manufacturing ENDS and e-liquids; nicotine warning statement; retail sales of ENDS, e-liquids, or their components or parts made or derived from tobacco; vape shops that mix e-liquids or modify products; importing ENDS and e-liquids; and reporting adverse experiences and product violations.

Contact: U.S. Food and Drug Administration, Office of Consumer Affairs, , 5600 Fishers Lane , Rockville, MD 20857, Telephone: (888) 463-6332 Fax: (301) 443-9767 E-mail: consumerinfo@fda.hhs.gov Web Site: http://www.fda.gov/consumer/default.htm Available from the website.

Keywords: Adverse effects, Consumer protection, Drug administration routes, Federal agencies, Nicotine, Public health, Regulations, Smoking

Children's Safety Network. 2016. Medication abuse prevention: 2016 resource guide. Waltham, MA: Children's Safety Network, 19 pp.

Annotation: This guide describes organizations, policy and legislation, prevention programs, publications, and webinars focused on prescription drug overdose prevention among youth and young adults. Contents include descriptions of reports, guides, toolkits, campaigns, website, iinitiatives, and research studies. Each item includes a short description and a link to the resource itself. Information about child safety and neonatal abstinence syndrome are included. [Funded by the Maternal and Child Health Bureau]

Contact: Children's Safety Network, Education Development Center, 43 Foundry Avenue, Waltham, MA 02453-8313, Telephone: (617) 618-2918 Fax: (617) 969-9186 E-mail: csninfo@edc.org Web Site: http://www.childrenssafetynetwork.org Available from the website.

Keywords: Adolescents, Children, Drug effects, Infants, Legislation, Multimedia, Neonatal abstinence syndrome, Policy development, Prescription drugs, Resource materials, Resources for professionals, Safety, Substance abuse prevention, Substance abuse prevention programs, Young adults

National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2016. Betel quid with tobacco (gutka). Atlanta, GA: Centers for Disease Control and Prevention, 1 p.

Annotation: This fact sheet provides information about the use and health effects of betel quid, a combination of betel leaf, areca nut, and slaked lime. Topics include betel quid and gutka (betel quid with tobacco) use by men and women and by region. Health issues associated with the use of betel quid and gutka such as precancerous conditions, cancer, reproductive health problems, and nicotine addiction are also discussed.

Contact: National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 Fax: E-mail: cdcinfo@cdc.gov Web Site: http://www.cdc.gov/tobacco Available from the website.

Keywords: Cancer, Drug effects, Nicotine, Oral health, Pregnant women, Preventive health services, Reproductive health, Risk factors, Smokeless tobacco, Tobacco use

University of Washington Health Sciences Administration, Alcohol and Drug Abuse Institute, Fetal Alcohol and Drug Unit. 2015. The Parent-Child Assistance Program (PCAP): Prevention & intervention with high-risk mothers and their children. Seattle, WA: Washington State Department of Social and Health Services, Division of Behavioral Health and Recovery, 6 pp.

Annotation: This brochure describes a program to prevent and/or reduce the risk of maternal alcohol and drug abuse by providing home visitation and intervention over a 3-year period by trained and supervised case managers. Contents include a description of the program goals, approach, client outcomes, and eligibility criteria. Topics include helping mothers build and maintain healthy independent family lives, assuring that children are in safe and stable homes, and preventing future births of alcohol and drug-exposed children.

Contact: University of Washington Health Sciences Administration, Alcohol and Drug Abuse Institute, Fetal Alcohol and Drug Unit, 180 Nickerson Street, Suite 309, Seattle, WA 98109, Telephone: (206) 543-7155 Fax: (206) 685-2903 Contact E-mail: granttm@uw.edu Web Site: http://depts.washington.edu/fadu Available from the website.

Keywords: Alcohol abuse, Alcohol use during pregnancy, Case management, Child safety, Drug abuse, Family support programs, Fetal alcohol effects, High risk children, High risk mothers, Home visiting, Postpartum care, Pregnancy, Pregnant women, Prenatal care, Program descriptions, Referrals, Risk factors, Substance abuse prevention programs, Substance abuse treatment services, Washington, Women

Orange County Health Department. 2015. Betel nut provider guide: The importance of screening for betel (areca) nut. Hillsborough, NC: Orange County Health Department, 2 pp.

Annotation: This document for health care professionals provides guidance on screening for betel (areca) nut use. Topics include what betel nut is and how it used, who is likely to chew betel nut, how to tell if someone chews betel nut, and why it is important to talk to patients about betel nut. Additional topics include adverse health effects of betel nut use for oral health and pregnancy outcomes, and what health professionals can do. Sample screening questions are included.

Contact: Orange County Health Department, P.O. Box 8181, Hillsborough, NC 27278, Telephone: (919) 732-8181 Web Site: http://www.orangecountync.gov/departments/health Available from the website.

Keywords: Cancer, Communication, Culturally competent services, Drug effects, Nicotine, Oral health, Pregnancy, Pregnant women, Preventive health services, Risk factors, Smokeless tobacco, Substance use screening, Tobacco use

Centers for Disease Control and Prevention. 2014-. Treating for two: Safer medication use in pregnancy. Atlanta, GA: Centers for Disease Control and Prevention, 1 v.

Annotation: This website provides resources from an initiative to prevent birth defects and improve the health of mothers by identifying alternatives for treatment of common conditions during pregnancy and during the childbearing years. Contents include information and resources for parents and clinicians on medication use before and during pregnancy, and while breastfeeding. Topics include planning for pregnancy, the effects of medications during pregnancy, lists of safe medications during pregnancy, discussing current medications, accidental exposure, and a peer-reviewed database of drugs to which women who are breastfeeding may be exposed.

Contact: Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 E-mail: cdcinfo@cdc.gov Web Site: http://www.cdc.gov Available from the website.

Keywords: Adverse effects, Breastfeeding, Drug therapy, Drugs, Federal initiatives, Pregnancy, Pregnant women, Self medication

National Institute for Health Care Management Foundation and Association of State and Territorial Health Officials. 2014. Neonatal abstinence syndrome: Strategies for states and health plans. Washington, DC: National Institute for Health Care Management Foundation, multiple items.

Annotation: These resources, from a webinar held on July 16, 2014, highlight strategies for preventing and treating neonatal abstinence syndrome (NAS). Contents include a recording of the speaker's presentations (1 hour, 27 min., 23 sec.), the webinar agenda and speaker biographies, and related materials. Topics include recent trends in opioid abuse and NAS, with an overview of federally-led prevention efforts; the impact of rising NAS rates across the states, including implications for Medicaid and examples of state-level action; a health plan-led initiative to improve care coordination and social support for pregnant women in treatment for addiction; and the latest in NAS treatment, and an assessment of where public and private investments would be most beneficial.

Contact: National Institute for Health Care Management Foundation, 1225 19th Street, N.W., Suite 710, Washington, DC 20036, Telephone: (202) 296-4426 Fax: (202) 296-4319 E-mail: http://www.nihcm.org/contact Web Site: http://www.nihcm.org Available from the website.

Keywords: Analgesic drugs, Collaboration, Drug addiction, Drug effects, Federal initiatives, Health care systems, Model programs, Neonatal abstinence syndrome, Newborns, Opiates, Pregnant women, Prevention programs, Public private partnerships, State MCH programs, Substance abuse treatment

Romito L, Mandiwala R. 2014. Tobacco cessation toolkit for Indiana dental practices. Indianapolis, IN: Indiana Dental Association, 93 pp.

Annotation: This toolkit provides information on how oral health professionals can develop a tobacco-cessation-intervention program and outlines key roles for each member of the oral health team. Contents include information about tobacco use and prevalence, risks of tobacco use, secondhand smoke, benefits of cessation, nicotine and the physiology of dependence, tobacco-cessation counseling, pharmacotherapy, insurance coverage and coding, the role of dentists and the dental team, barriers and solutions, and resources.

Contact: Indiana Dental Association, 1319 East Stop 10 Road, Indianapolis, IN 46227, Telephone: (317) 634-2610 Secondary Telephone: (800) 562-5646 Fax: (317) 634-2612 E-mail: jhawke@indental.org Web Site: http://www.indental.org/ Available from the website.

Keywords: Adverse effects, Barriers, Counseling, Dental care, Drug dependence, Health insurance, Indiana, Intervention, Nicotine, Oral health, Program development, Reimbursement, Role, Smoking cessation, State programs, Tobacco use

National Library of Medicine, Toxicology and Environmental Health Information Program. 2011. LactMed. Bethesda, MD: National Library of Medicine, Toxicology and Environmental Health Information Program, 1 v.

Annotation: This mobile application provides information about drugs and breastfeeding. Topics include maternal and infant drug levels, possible effects on lactation and on breastfed infants, and alternative drugs to consider. The application is available for iPhone/iPod Touch or Android devices.

Contact: National Library of Medicine, Toxicology and Environmental Health Information Program, Specialized Information Services, Two Democracy Plaza, Suite 510, 6707 Democracy Plaza, MSC 5467, Bethesda, MD 20892-5467, Telephone: (301) 496-1131 Fax: (301) 480-3537 E-mail: tehip@teh.nlm.nih.gov Web Site: http://sis.nlm.nih.gov/enviro.html Available from the website.

Keywords: Adverse effects, Breastfeeding, Drug effects, Infant health, Lactation, Mobile applications, Software

National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2010. How tobacco smoke causes disease: What it means to you–A report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, 16 pp.

Annotation: This document summarizes scientific findings about how deadly cigarettes are, how quickly they can damage the body, and ways that tobacco companies have altered cigarettes to make them more addictive. Topics include the chemicals in tobacco smoke; nicotine and addiction; how smoking causes cancer and circulatory and respiratory damage, harms reproduction and children's health, and makes diabetes harder to control; and how secondhand smoke harms nonsmokers. Information about the reasons people chose to quit smoking and resources to help them is included.

Contact: National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 Fax: E-mail: cdcinfo@cdc.gov Web Site: http://www.cdc.gov/tobacco Available from the website.

Keywords: Adverse effects, Advertising, Child health, Consumer education materials, Drug addiction, Nicotine, Oral health, Research, Smoking, Smoking cessation

American Dental Association. 2003–. Fluoridation videos. Chicago, IL: American Dental Association, multiple items.

Annotation: This series of videos for consumers provides information about fluoride in community water, bottled water, and home-water-treatment systems. Additional videos presented by dentists provide information about the benefits of fluoride for dental caries prevention in adults; fluoride and bone cancer; the role of environmental and policy changes and individual behavior change in preventing dental caries; fluoride and neurotoxicity, fluorosis, and infant formula and fluoridated water.

Contact: American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611-2678, Telephone: (312) 440-2500 Fax: (312) 440-7494 E-mail: info@ada.org Web Site: http://www.ada.org Available from the website.

Keywords: Adults, Community role, Dental caries, Drug effects, Fluorides, Health behavior, Infants, Oral health, Preventive health services, Public policy, Water

U.S. General Accounting Office. 2003. Pediatric drug research: Food and Drug Administration should more efficiently monitor inclusion of minority children. Washington, DC: U.S. General Accounting Office, 29 pp.

Annotation: This report addresses the Food and Drug Administration's (FDA's) concern that drug effectiveness and adverse affects can vary among children from different racial and ethnic groups. The report focusing on the following questions: (1) to what extent are children of racial and ethnic minority groups represented in clinical studies for drugs granted exclusive marketing rights, (2) are drugs that are used to treat diseases that disproportionately affect racial and ethnic minority groups being studied for safety and effectiveness in children under the pediatric exclusivity provision, and (3) does the Food and Drug Administration have appropriate management systems to monitor the representation of children of racial and ethnic groups in studies submitted for additional exclusive marketing rights? Statistical information is presented in tables throughout the report. The report includes four appendices that discuss the study's scope and provide additional supplemental information.

Contact: U.S. Government Accountability Office, 441 G Street, N.W., Washington, DC 20548, Telephone: (202) 512-3000 Secondary Telephone: E-mail: contact@gao.gov Web Site: http://www.gao.gov Available from the website. Document Number: GAO-03-950.

Keywords: Child safety, Children, Drug effects, Food and Drug Administration, Minority groups, Minority health, Racial factors

National Cancer Institute. 2001. Young people with cancer: A handbook for parents. Bethesda, MD: National Cancer Institute, 109 pp.

Annotation: This book, which is geared toward parents with a child who has cancer, provides information on all stages of a child's illness. It tells parents what to expect and suggests ways to prepare for different situations. Information about the following topics is included: (1) what cancer is and what the different kinds of cancers are, (2) how to find the best treatment, (3) cancer treatment and side effects, (4) common medical procedures, (5) how to talk to your child about cancer, (6) how to handle your own feelings, your child's feelings, and the feelings of others, (7) common health issues, (8) what the future holds, and (9) where to get more information. The book also includes a list of resources, a dictionary, and one appendix -- common childhood cancers.

Contact: National Cancer Institute, 6116 Executive Boulevard, Suite 300, Bethesda, MD 20892-8322, Telephone: (800) 422-6237 Secondary Telephone: Fax: (301) 402-0555 E-mail: cancergovstaff@mail.nih.gov Web Site: http://www.cancer.gov Available at no charge; also available from the website. Document Number: NIH pub. no. 04-2378.

Keywords: Cancer, Child health, Children, Communication, Drug effects, Emotions, Families, Parent child relations, Parents, Treatment

Harris LS, ed. 1995. Problems of drug dependence,1994: Proceedings of the 56th Annual Scientific Meeting, the College on Problems of Drug Dependence. Rockville, MD: National Institute on Drug Abuse, 2 v. (NIDA Research Monograph series 152 and 153)

Annotation: This monograph is based on papers or presentations from the 56th Annual Scientific Meeting of the College on Problems of Drug Dependence. It is highly clinical in nature and covers many different aspects of drug dependence and substance abuse including behavior, treatment, policy, impact, and health issues. Volume 1 contains plenary sessions and annual reports, and Volume 2 contains abstracts.

Contact: National Institute on Drug Abuse, 6001 Executive Boulevard, Room 5213, MSC 9561, Bethesda, MD 20892-9561, Telephone: (301) 443-1124 Secondary Telephone: Fax: Web Site: http://www.nida.nih.gov Available in libraries. Document Number: NIH 95-3882.

Keywords: Drug abuse, Drug dependence, Drug effects, Drug use behavior, Medical research, Substance abuse, Substance dependence

Shapiro BS, Schechter NL, Ohene-Frempong K, eds. 1994. Sickle cell disease related pain: Assessment and management—Conference proceedings. Mount Desert, ME: New England Regional Genetics Group, 53 pp.

Annotation: These proceedings discuss the assessment of pain, pharmacological management of pain, non-pharmacological management of pain, consumers' perspective on pain management, and discussions on these topics. [Funded by the Maternal and Child Health Bureau]

Contact: NERGG, Inc., P.O. Box 920288, Needham, MA 02492, Telephone: (781) 444-0126 Fax: (781) 444-0127 E-mail: mfgnergg@verizon.net Web Site: http://www.nergg.org Available in libraries.

Keywords: Adverse effects, Analgesic drugs, Conference proceedings, Disease management, Pain, Sickle cell disease, Sickle cell trait

U.S. Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Office for Substance Abuse Prevention. 1992. Identifying the needs of drug-affected children: Public policy issues. Rockville, MD: U.S. Department of Health and Human Services, Office for Substance Abuse Prevention, 168 pp. (OSAP prevention monograph; 11)

Annotation: This monograph contains the papers presented at the Issue Forum on Drug-Exposed Children Ages 2 to 5 held in November, 1990. The forum was held to determine the needs of drug-exposed children between the ages 2 to 5, and to develop intervention strategies. The forum focused on their special physical and psychological needs that need attention prior to their entering the public school system. Participants brought together expertise from the medical, child welfare, psychosocial, developmental, legal, and political and advocacy disciplines; and the topics considered also ranged across these disciplines. A list of the participants and the schedule from the forum are included.

Keywords: Child development, Drug affected children, Drug affected children, Educational factors, Fetal alcohol effects, Health services, Public policy, Social consequences

   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.